Table 4 Table summarizes chemotherapeutic regimen used to treat patients in the present study.
From: Outcome of recurrent and metastatic small cell carcinoma of the bladder
Regimen | Schedule | Drugs and doses | Â | Â | Â |
|---|---|---|---|---|---|
EP | On day 1 to 3, repeated after 21 days | Etoposide 120 mg/m2 on day 1 to 3 | Cisplatin 80 mg/m2, on day 1 | Â | Â |
MVAC | On day 1, 2, 15, and 22, repeated after 28 days | Methotrexate 30 mg/m2 on day 1, 15 and 22 | Vimblastine 3 mg/m2 on day 2, 15, and 22 | Doxorubicin 30 mg/m2 on day 2 | Cispatin 70 mg/m2 on day 2 |
GC | On day 1, 2, 8, and 15, repeated every 28 days | Gemcitabine 1000 mg/m2 on day 1, 8 and 15 | Cisplatin 70 mg/m2, on day 2 | Â | Â |
G | On day 1, 8 and 15 repeated after 21 days | Gemcitabine 1000 mg/m2 | Â | Â | Â |